- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 30.06. | Why Hospitals Must Rethink Operations Before Banking on AI | ||
| 29.06. | Why Employers Think the 340B Program Needs Reform | ||
| 29.06. | BioCryst Pharma Sells European Business for Rare Disease Drug in $250M Deal | ||
| 29.06. | No Wrong Door: How Policy, Technology & Partnerships Can Power a Connected Social Safety Net | ||
| 29.06. | The Administration's Autism Plan Is Controversial - But It Also Presents a Vital Opportunity | ||
| 29.06. | The $232 Billion Problem: The Price of Overlooking the Impact of Trauma in the U.S. | ||
| 27.06. | FDA Just Made Key Some Key Regulatory Changes to Make Cancer Cell Therapies More Accessible | ||
| 27.06. | Who is Speaking About AI at MedCity INVEST Digital Health in Dallas? | ||
| 27.06. | MedCity Pivot Podcast: Mayo Clinic Florida Redefines Cancer Care | ||
| 27.06. | Expert Care in Houston: Top-Rated Hand and Wrist Surgeons You Can Trust | ||
| 27.06. | Data Technology + RWD Are Positive for Rare Disease Treatment | ||
| 27.06. | Certify Raises $40M To Advance Healthcare Provider Data Infrastructure | ||
| 26.06. | Vor Bio Reinvents Itself as an Autoimmune Biotech With In-Licensed Phase 3 Asset and $175M in Funding | ||
| 26.06. | From Burnout to Breakthrough: Reinventing Pediatric Care for the Next Generation | ||
| 26.06. | Beyond Technology: Aligning AI Tools with Systemic Change in Healthcare | ||
| 26.06. | What VCs Have Learned About Health Tech in the Public Markets | ||
| 26.06. | EnsoData Snags $20M to Improve Sleep Disorder Diagnostics | ||
| 25.06. | Novavax Sees Sanofi Vaccine Pact as Model for Future Deals, Some Going Beyond Infectious Disease | ||
| 25.06. | How More Competition and Better Connected Data Will Solve Healthcare's Billion Dollar Problem | ||
| 25.06. | A Father's Promise: Breaking the Cycle of Trauma and Addiction for My Son | ||
| 25.06. | Hackers Use AI to Amplify Email Security Threats to Healthcare | ||
| 25.06. | The Hospital Word Has Become a Tale of the Haves and Have-Nots | ||
| 25.06. | Why Novo Nordisk Is Dropping Its Collaboration with Hims & Hers | ||
| 24.06. | Nektar's Novel Eczema Drug Meets Trial Goals, But Differentiation From Dupixent Remains Unclear | ||
| 24.06. | From Data Silos to Integrated Care: Driving Provider Engagement |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .